ACIP Recommendations: Meningococcal Vaccine

Published in Morbidity and Mortality Weekly Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

CURRENT Meningococcal vaccine recommendations

• MMWR, April 18, 2024, Vol 73(15);345–350
  Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023 | MMWR (cdc.gov)
• MMWR, September 25, 2020, Vol 69(9);1–41
  Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
  Print version
• See also: ACIP-VFC Resolution

ARCHIVED historical Meningococcal immunization publications

For your convenience, these archived publications can be used for historical and research purposes.

• MMWR, May 19, 2017, Vol 66(19);509–513
  Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
  Print version
• MMWR, November 4, 2016, Vol 65(43);1189–1194
  Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016
  Print version
• MMWR, October 23, 2015, Vol 64(41);1171-6
  Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
  Print version
• MMWR, June 12, 2015, Vol 64(22);608-612
  Use of Serogroup B Meningococcal (MenB) Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
  Print version
• MMWR, June 20, 2014, Vol 63(24);527-530
  Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk, 2013
  Print version
• MMWR, March 22, 2013, Vol 62(RR-02);1-22
  Prevention and Control of Meningococcal Disease
  Print version
• MMWR, January 25, 2013, Vol 62(03);52-54
  Infant Meningococcal Vaccination: ACIP Recommendations and Rationale
  Print version
• MMWR, October 14, 2011, Vol 60(40);1391-1392
  Recommendation of the ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
  Print version
• MMWR, August 5, 2011, Vol 60(30);1018-1019
  Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — ACIP, 2011
  Print version
• MMWR, January 28, 2011, Vol 60(03);72-76
  Updated Recommendations for Use of Meningococcal Conjugate Vaccines — ACIP, 2010
  Print version
• MMWR, March 12, 2010, Vol 59(09);273
  Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use — ACIP, 2010
  Print version
• MMWR, September 25, 2009, Vol 58(37);1042-1043
  Updated Recommendation from the ACIP for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
  Print version
• MMWR, May 2, 2008, Vol 57(17);462-465
  Report from ACIP: Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
  (PDF not available)
• MMWR, December 7, 2007, Vol 56(48);1265-1266
  Notice to Readers: Recommendation from ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 Years at Increased Risk for Invasive Meningococcal Disease
  Print version
• MMWR, August 10, 2007, Vol 56(31);794-795
  Notice to Readers: Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine
  Print version
• MMWR, November 3, 2006, Vol 55(43);1177
  Notice to Readers: Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11-12 Years
  Print version
• MMWR, September 22, 2006, Vol 55(37);1016-1017
  Inadvertent Misadministration of Meningococcal Conjugate Vaccine — United States, June-August 2005
  Print version
• MMWR, May 26, 2006, Vol 55(20);567-568
  Notice to Readers: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11-12 Years
  Print version
• MMWR, May 27, 2005, Vol 54(RR-07);1-21
  Prevention and Control of Meningococcal Disease
  Print version
• MMWR, Feb 14, 1997, Vol 46(RR-5);13-21
  Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks: Recommendations of the ACIP
  Print version